1,9-dideoxyforskolin has been researched along with 8-bromoadenosine-3',5'-cyclic monophosphorothioate in 1 studies
| Studies (1,9-dideoxyforskolin) | Trials (1,9-dideoxyforskolin) | Recent Studies (post-2010) (1,9-dideoxyforskolin) | Studies (8-bromoadenosine-3',5'-cyclic monophosphorothioate) | Trials (8-bromoadenosine-3',5'-cyclic monophosphorothioate) | Recent Studies (post-2010) (8-bromoadenosine-3',5'-cyclic monophosphorothioate) |
|---|---|---|---|---|---|
| 111 | 0 | 2 | 60 | 0 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, XZ; Jin, D; Kim, DH; Lee, KJ; Li, JH; Qi, XF; Song, SB; Teng, YC; Yoon, YS | 1 |
1 other study(ies) available for 1,9-dideoxyforskolin and 8-bromoadenosine-3',5'-cyclic monophosphorothioate
| Article | Year |
|---|---|
The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Adenylyl Cyclases; Bucladesine; Chemokine CCL17; Chemokine CCL22; Colforsin; Cyclic AMP; Enzyme Activation; Humans; Interferon-gamma; Keratinocytes; Models, Immunological; NF-kappa B; p38 Mitogen-Activated Protein Kinases; STAT1 Transcription Factor; Thionucleotides; Tumor Necrosis Factor-alpha | 2009 |